Broadway Financial (BYFC) Research & Development (2016 - 2025)

Broadway Financial has reported Research & Development over the past 11 years, most recently at $763000.0 for Q4 2025.

  • Quarterly results put Research & Development at $763000.0 for Q4 2025, up 19.41% from a year ago — trailing twelve months through Dec 2025 was $3.0 million (up 8.98% YoY), and the annual figure for FY2025 was $3.0 million, up 8.98%.
  • Research & Development for Q4 2025 was $763000.0 at Broadway Financial, down from $768000.0 in the prior quarter.
  • Over the last five years, Research & Development for BYFC hit a ceiling of $2.2 million in Q4 2021 and a floor of $27000.0 in Q1 2022.
  • Median Research & Development over the past 5 years was $711000.0 (2023), compared with a mean of $723150.0.
  • Biggest five-year swings in Research & Development: crashed 88.8% in 2022 and later skyrocketed 2548.15% in 2023.
  • Broadway Financial's Research & Development stood at $2.2 million in 2021, then crashed by 74.4% to $569000.0 in 2022, then rose by 10.54% to $629000.0 in 2023, then rose by 1.59% to $639000.0 in 2024, then grew by 19.41% to $763000.0 in 2025.
  • The last three reported values for Research & Development were $763000.0 (Q4 2025), $768000.0 (Q3 2025), and $774000.0 (Q2 2025) per Business Quant data.